Cargando…

Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease

RATIONALE: We had shown that COPD women expressed more dyspnea than men for the same degree of airway obstruction. OBJECTIVES: Evaluate gender differences in respiratory factors associated with dyspnea in COPD patients. METHODS: In a FEV(1 )% matched population of 100 men and women with COPD we meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Torres, Juan P, Casanova, Ciro, Montejo de Garcini, Angela, Aguirre-Jaime, Armando, Celli, Bartolome R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821020/ https://www.ncbi.nlm.nih.gov/pubmed/17341300 http://dx.doi.org/10.1186/1465-9921-8-18

Ejemplares similares

COPD heterogeneity: Gender differences in the multidimensional BODE index
por: de Torres, Juan P, et al.
Publicado: (2007)

Gender associated differences in determinants of quality of life in patients with COPD: a case series study
por: de Torres, Juan P, et al.
Publicado: (2006)

Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study
por: de Torres, Juan P., et al.
Publicado: (2011)

Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
por: Divo, Miguel J., et al.
Publicado: (2022)

TNFA-863 polymorphism is associated with a reduced risk of Chronic Obstructive Pulmonary Disease: A replication study
por: Córdoba-Lanús, Elizabeth, et al.
Publicado: (2011)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Finding the Best Thresholds of FEV(1) and Dyspnea to Predict 5-Year Survival in COPD Patients: The COCOMICS Study
por: Almagro, Pere, et al.
Publicado: (2014)

Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Córdoba-Lanús, Elizabeth, et al.
Publicado: (2023)

Erratum to: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort
por: Cordoba-Lanus, Elizabeth, et al.
Publicado: (2017)

Telomere shortening and accelerated aging in COPD: findings from the BODE cohort
por: Elizabeth, Córdoba-Lanús, et al.
Publicado: (2017)

Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease
por: Chhabra, S. K., et al.
Publicado: (2009)

Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Vozoris, Nicholas T.
Publicado: (2021)

Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease
por: Mahut, Bruno, et al.
Publicado: (2012)

Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease
por: Zagaceta, Jorge, et al.
Publicado: (2013)

Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study
por: Cabrera, Carlos, et al.
Publicado: (2016)

The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice
por: Nishimura, Koichi, et al.
Publicado: (2023)

From Laënnec’s Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome
Publicado: (2023)

Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease
por: Perez, Thierry, et al.
Publicado: (2015)

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
por: Celli, Bartolome R, et al.
Publicado: (2012)

Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort
por: Divo, Miguel J., et al.
Publicado: (2018)

Brain Activation during Perception and Anticipation of Dyspnea in Chronic Obstructive Pulmonary Disease
por: Esser, Roland W., et al.
Publicado: (2017)

Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Mammen, Manoj J., et al.
Publicado: (2021)

Impact of Exercise Capacity Upon Respiratory Functions, Perception of Dyspnea, and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
por: Liu, Wenjun, et al.
Publicado: (2021)

Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study
por: Oga, Toru, et al.
Publicado: (2012)

Anthropometric Indicators Associated with Dyspnea and Spirometric Parameters in Patients with Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2016)

Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients
por: Castro, Antonio A.M., et al.
Publicado: (2012)

The effect of the presence and severity of bronchiectasis on the respiratory functions, exercise capacity, dyspnea perception, and quality of life in patients with chronic obstructive pulmonary disease
por: Sahin, Hulya, et al.
Publicado: (2020)

Markers of exacerbation severity in chronic obstructive pulmonary disease
por: Franciosi, Luigi G, et al.
Publicado: (2006)

Effect of Self-Management Program on Health Status and Dyspnea in Patients with Chronic Obstructive Pulmonary Disease
por: Hasanpour Dehkordi, Ali, et al.
Publicado: (2022)

Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease
por: Kelly, Emer, et al.
Publicado: (2013)

The minimal important difference of the pulmonary functional status and dyspnea questionnaire in patients with severe chronic obstructive pulmonary disease
por: Regueiro, Eloisa MG, et al.
Publicado: (2013)

Reply to Pouwels et al.: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Stockley, Robert A., et al.
Publicado: (2019)

Postdeployment Respiratory Syndrome in Soldiers With Chronic Exertional Dyspnea
por: Gutor, Sergey S., et al.
Publicado: (2021)

Respiratory system as the main determinant of dyspnea in patients with pulmonary hypertension
por: Mitrouska, Ioanna, et al.
Publicado: (2022)

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2015)

Evaluation of Quality of Life with the Chronic Obstructive Pulmonary Disease Assessment Test in Chronic Obstructive Pulmonary Disease and the Effect of Dyspnea on Disease-Specific Quality of Life in These Patients
por: Okutan, Oguzhan, et al.
Publicado: (2013)

Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease
por: Alyami, Mohammed M., et al.
Publicado: (2015)

The relationship of dyspnea and disease severity with anthropometric indicators of malnutrition among patients with chronic obstructive pulmonary disease
por: Baig, Mirza Muhammad Ayub, et al.
Publicado: (2018)

Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
por: Hildreth, Leah, et al.
Publicado: (2020)

The concomitant assessment of pain and dyspnea in acute exacerbations of chronic obstructive pulmonary disease; is pain an understudied factor?
por: Hume, Emily
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_144qq1d0b59p0nujfic79il5tb